Students' knowledge of COPD: projects ASCO-1 and ASCO-2 results comparison

被引：0
|
作者：
Bontsevich, Roman [1 ]
Filinichenko, Tatyana [1 ]
Gavrilova, Anna [1 ]
Shchurovskaya, Kristina [1 ]
Batisheva, Galina [2 ]
Goncharova, Natalya [2 ]
Ketova, Galina [3 ]
Barysheva, Valeriya [3 ]
Myronenko, Olena [4 ]
Kompaniets, Olga [5 ]
Miliutina, Elena [1 ]
Mikhno, Alina [6 ]
Zhdanova, Zhanna [1 ]
机构：
[1] Belgorod State Natl Res Univ, Belgorod, Russia
[2] Voronezh State Med Univ, Voronezh, Russia
[3] South Ural State Med Univ, Chelyabinsk, Russia
[4] Dnipropetrovsk Med Acad, Dnipro, Ukraine
[5] Kuban State Med Univ, Krasnodar, Russia
[6] LLC MAKSBelmed, Belgorod, Russia
来源：
EUROPEAN RESPIRATORY JOURNAL | 2019年 / 54卷
关键词：
COPD; Education;
D O I：
10.1183/13993003.congress-2019.PA1485
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA1485
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Comparison of phase I trial (P1T) abstract quality between the EORTC-NCI-AACR and ASCO meetings
    Ho, J.
    Strevel, E.
    Chau, N.
    Pond, G. R.
    Murgo, A.
    Ivy, P.
    Siu, L. L.
    EJC SUPPLEMENTS, 2008, 6 (12): : 120 - 120
  • [32] Impact of repeat HER2 testing after initial equivocal HER2 FISH results using 2013 ASCO/CAP guidelines
    Xu, Fang-Ping
    Wang, Kun
    Xu, Jie
    Chen, Jie
    Zhang, Yi-Fang
    Wu, Hong-Mei
    Zhang, Ming-Hui
    Long, Xiao-Xu
    Luo, Xin-Lan
    Zhang, Ke-Ping
    Lin, Dan-Yi
    Liu, Yan-Hui
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 166 (03) : 757 - 764
  • [33] Impact of repeat HER2 testing after initial equivocal HER2 FISH results using 2013 ASCO/CAP guidelines
    Fang-Ping Xu
    Kun Wang
    Jie Xu
    Jie Chen
    Yi-Fang Zhang
    Hong-Mei Wu
    Ming-Hui Zhang
    Xiao-Xu Long
    Xin-Lan Luo
    Ke-Ping Zhang
    Dan-Yi Lin
    Yan-Hui Liu
    Breast Cancer Research and Treatment, 2017, 166 : 757 - 764
  • [34] Impact of the 2018 ASCO/CAP guidelines on HER2 fluorescence in situ hybridization interpretation in invasive breast cancers with immunohistochemically equivocal results
    Bo Wang
    Wei Ding
    Ke Sun
    Xiaoling Wang
    Liming Xu
    Xiaodong Teng
    Scientific Reports, 9
  • [35] Impact of the 2018 ASCO/CAP HER2 Guideline Updates on HER2 Assessment in Breast Cancer with HER2 Immunohistochemistry Equivocal Results
    Wen, Hannah
    Ventura, Katia
    Xu, Jin
    Ross, Dara
    Dang, Chau
    Robson, Mark
    Norton, Larry
    Morrow, Monica
    Brogi, Edi
    MODERN PATHOLOGY, 2019, 32
  • [36] Impact of the 2018 ASCO/CAP HER2 Guideline Updates on HER2 Assessment in Breast Cancer with HER2 Immunohistochemistry Equivocal Results
    Wen, Hannah
    Ventura, Katia
    Xu, Jin
    Ross, Dara
    Dang, Chau
    Robson, Mark
    Norton, Larry
    Morrow, Monica
    Brogi, Edi
    LABORATORY INVESTIGATION, 2019, 99
  • [37] Impact of the 2018 ASCO/CAP guidelines on HER2 fluorescence in situ hybridization interpretation in invasive breast cancers with immunohistochemically equivocal results
    Wang, Bo
    Ding, Wei
    Sun, Ke
    Wang, Xiaoling
    Xu, Liming
    Teng, Xiaodong
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [38] COVID-19 vaccine uptake in patients with cancer and Sars-Cov-2 infection in 2020: Results from the ASCO registry.
    Williams, Jen Hanley Hanley
    Bruinooge, Suanna Steeby
    Kaltenbaugh, Melinda
    Gralow, Julie R.
    Garrett-Mayer, Elizabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18713 - E18713
  • [39] Impact of the 2013 ASCO/CAP HER2 revised guidelines on HER2 results in breast core biopsies with invasive breast carcinoma: a retrospective study
    Overcast, Wynton B.
    Zhang, Jianying
    Zynger, Debra L.
    Tozbikian, Gary H.
    VIRCHOWS ARCHIV, 2016, 469 (02) : 203 - 212
  • [40] Impact of the 2013 ASCO/CAP HER2 revised guidelines on HER2 results in breast core biopsies with invasive breast carcinoma: a retrospective study
    Wynton B. Overcast
    Jianying Zhang
    Debra L. Zynger
    Gary H. Tozbikian
    Virchows Archiv, 2016, 469 : 203 - 212
12345